ADJUVANT CHEMOTHERAPY IS NOT ASSOCIATED WITH IMPROVED OVERALL SURVIVAL IN PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA WITH PERSISTENT LYMPHOVASCULAR INVASION OR LYMPH NODE INVOLVEMENT AFTER NEOADJUVANT CHEMOTHERAPY

被引:0
|
作者
Armstrong, Valerie
Chang, Yu-Hui
Kartik, Akash
Stucky, Chee-Chee
Pai, Rish
Sonbol, Mohamad B.
Wu, Christina
Borad, Mitesh
Bekaii-Saab, Tanios
Wasif, Nabil
Fong, Zhi Ven
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
375
引用
收藏
页码:S1795 / S1795
页数:1
相关论文
共 50 条
  • [21] Multiagent Adjuvant Chemotherapy Associated with Improved Overall Survival in Resected Ampullary Adenocarcinoma
    Olecki, Elizabeth
    Brahmbhatt, Ruskin
    Vining, Charles
    Peng, June
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S198 - S199
  • [22] Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX
    Lee, So Heun
    Hwang, Dae Wook
    Yoo, Changhoon
    Kim, Kyu-pyo
    Kang, Sora
    Jeong, Jae Ho
    Oh, Dongwook
    Song, Tae Jun
    Lee, Sang Soo
    Park, Do Hyun
    Seo, Dong Wan
    Park, Jin-hong
    Song, Ki Byung
    Lee, Jae Hoon
    Lee, Woohyung
    Park, Yejong
    Kwak, Bong Jun
    Chang, Heung-Moon
    Ryoo, Baek-Yeol
    Kim, Song Cheol
    CANCER RESEARCH AND TREATMENT, 2023, 55 (03): : 956 - 968
  • [23] Lymphovascular invasion and survival in breast cancer after neoadjuvant chemotherapy.
    Liu, Ying
    Saraf, Anurag
    Lee, Shing Mirn
    Zhong, Xiaobo
    Kalinsky, Kevin
    Connolly, Eileen
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [24] Association of Adjuvant Chemotherapy with Overall Survival in Resected Pancreatic Adenocarcinoma Previously Treated with Neoadjuvant Therapy
    Swords, D. S.
    Garrido-Laguna, I.
    Mulvihill, S. J.
    Stoddard, G. J.
    Firpo, M. A.
    Scaife, C. L.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S116 - S116
  • [25] Does the Mechanism of Lymph Node Invasion Affect Survival in Patients with Pancreatic Ductal Adenocarcinoma?
    Ioannis T. Konstantinidis
    Vikram Deshpande
    Hui Zheng
    Jennifer A. Wargo
    Carlos Fernandez-del Castillo
    Sarah P. Thayer
    Vasiliki Androutsopoulos
    Gregory Y. Lauwers
    Andrew L. Warshaw
    Cristina R. Ferrone
    Journal of Gastrointestinal Surgery, 2010, 14 : 261 - 267
  • [26] Does the Mechanism of Lymph Node Invasion Affect Survival in Patients with Pancreatic Ductal Adenocarcinoma?
    Konstantinidis, Ioannis T.
    Deshpande, Vikram
    Zheng, Hui
    Wargo, Jennifer A.
    Fernandez-del Castillo, Carlos
    Thayer, Sarah P.
    Androutsopoulos, Vasiliki
    Lauwers, Gregory Y.
    Warshaw, Andrew L.
    Ferrone, Cristina R.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2010, 14 (02) : 261 - 267
  • [27] What is the Impact of Neoadjuvant Chemotherapy on Survival after Palliative Procedures for Pancreatic Ductal Adenocarcinoma?
    Halle-Smith, James
    Roberts, Keith
    BRITISH JOURNAL OF SURGERY, 2022, 109
  • [28] Clarifying the role of adjuvant therapy after multi-agent neoadjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma
    Lan, Xiaoyang
    Abdel-Rahman, Omar
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (08) : 2232 - 2234
  • [29] Addition of Adjuvant Radiation to Adjuvant Chemotherapy Does Not Improve Survival in Patients with Advanced Pancreatic Adenocarcinoma Treated with Neoadjuvant Chemotherapy
    Ruiz, Meritxell
    Leyva-Alvizo, Adolfo
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2022, 235 (05) : S145 - S146
  • [30] Impact of Margin Status on Survival in Patients with Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Chemotherapy
    Schmocker, Ryan K.
    Delitto, Daniel
    Wright, Michael J.
    Ding, Ding
    Cameron, John L.
    Lafaro, Kelly J.
    Burns, William R.
    Wolfgang, Christopher L.
    Burkhart, Richard A.
    He, Jin
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2021, 232 (04) : 405 - 413